Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT00837928 : Bendamustine and Radiation Therapy in Treating Patients With Brain Metastases Caused by Solid Tumors
PhasePhase 1
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

- Histologically confirmed cancer with 1 to 4 brain metastases imaged by MRI/CT scans
not involving thalamus, basal ganglia or brain stem.

- No cancer originating in central nervous system

- Candidate for clinically indicated surgery to resect brain lesions.

- Karnofsky score of at least 60

- At least 18 years of age

- Life expectancy of more than two months

Exclusion Criteria:

- Evidence of leptomeningeal metastases.

- Need immediate treatment to prevent neurological deterioration.

- Prior brain radiotherapy or surgery for current brain metastases.

- Radiosensitive primary tumors such as small cell lung cancer, germ cell tumors,
lymphoma, leukemia or multiple myeloma.

- Absolute neutrophil count (ANC)<1500/mm3 or platelets <50,000/mms.

- Brain metastasis diameter greater than 5 cm.

- Not pregnant or nursing

- More than 3 weeks since prior chemotherapy.

- No evidence of ischemia on EKG and/or reduced cardiac ejection fraction (i.e., < 50%)
on ECHO.

- No known sensitivity or allergy to bendamustine hydrochloride or mannitol

- No more than 3 prior cytotoxic chemotherapy regimens

- No unresolved persistent toxicities for 4 weeks from prior chemotherapy or 6 weeks
for nitrosoureas.

- Calculated creatinine clearance <40 ml/min.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT00837928      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740